RVMD · Revolution Medicines, Inc. · Held by Funds
$205.26
+0.78 (+0.38%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$43.93B
Shares
214.34M
Volume · Sep 30
1.85M
Avg daily vol (3M)
1.94M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding RVMD
530 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,412,413 | $1,200,916,707 | 0.05% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 4,631,150 | $867,321,772 | 0.46% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 2,670,853 | $500,197,350 | 1.06% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,291,511 | $429,154,180 | 0.44% | Long | 2026-06-30 | |
| Fidelity Growth Company Fund | — | 2,475,942 | $389,911,346 | 0.39% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE FUND | — | 1,988,729 | $372,946,349 | 0.98% | Long | 2026-07-31 | |
| Growth Fund of America | — | 1,838,422 | $289,514,697 | 0.08% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | IBB | 1,349,118 | $252,662,819 | 2.78% | Long | 2026-06-30 | |
| JPMorgan Large Cap Growth Fund | — | 1,166,558 | $218,472,982 | 0.18% | Long | 2026-06-30 | |
| iShares Russell Mid-Cap Growth ETF | IWP | 1,128,977 | $211,434,813 | 0.98% | Long | 2026-06-30 | |
| Fidelity OTC Portfolio | — | 1,002,878 | $188,069,711 | 0.44% | Long | 2026-07-31 | |
| Janus Henderson Enterprise Fund | — | 978,312 | $183,218,271 | 0.82% | Long | 2026-06-30 | |
| Janus Henderson Forty Fund | — | 937,887 | $175,647,477 | 0.74% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 936,558 | $175,398,582 | 3.02% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 1,011,551 | $159,299,051 | 0.37% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 942,767 | $148,466,947 | 0.65% | Long | 2026-05-31 | |
| iShares Russell Mid-Cap ETF | IWR | 786,979 | $147,385,427 | 0.26% | Long | 2026-06-30 | |
| iShares Russell 1000 Growth ETF | IWF | 730,570 | $136,821,150 | 0.11% | Long | 2026-06-30 | |
| Fidelity Mid Cap Index Fund | FSMDX | 724,852 | $135,931,496 | 0.26% | Long | 2026-07-31 | |
| Growth Fund | — | 715,338 | $133,968,501 | 0.23% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 690,499 | $129,316,653 | 1.20% | Long | 2026-06-30 | |
| Lord Abbett Growth Leaders Fund | — | 613,872 | $115,119,416 | 1.55% | Long | 2026-07-31 | |
| Franklin Dynatech Fund | — | 600,000 | $112,368,000 | 0.37% | Long | 2026-06-30 | |
| Fidelity Growth Company K6 Fund | FGKFX | 682,871 | $107,538,525 | 0.39% | Long | 2026-05-31 | |
| Select Biotechnology Portfolio | FBIOX | 675,072 | $106,310,339 | 2.02% | Long | 2026-05-31 | |
| Janus Henderson Triton Fund | — | 563,888 | $105,604,945 | 1.78% | Long | 2026-06-30 | |
| MFS Mid Cap Growth Fund | — | 654,055 | $103,000,581 | 0.75% | Long | 2026-05-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 527,759 | $98,838,706 | 0.67% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 495,491 | $92,795,554 | 0.78% | Long | 2026-06-30 | |
| Fidelity Series Growth Company Fund | FCGSX | 576,602 | $90,803,283 | 0.37% | Long | 2026-05-31 | |
| Fidelity Contrafund | — | 477,800 | $89,482,384 | 0.05% | Long | 2026-06-30 | |
| Federated Hermes MDT Mid Cap Growth Fund | — | 461,570 | $86,558,222 | 1.31% | Long | 2026-07-31 | |
| Schwab U.S. Mid-Cap ETF | SCHM | 530,570 | $83,554,164 | 0.57% | Long | 2026-05-31 | |
| Janus Henderson Research Fund | — | 412,224 | $77,201,311 | 0.26% | Long | 2026-06-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 485,701 | $76,488,193 | 0.40% | Long | 2026-05-31 | |
| Janus Henderson Venture Fund | — | 384,421 | $71,994,365 | 1.99% | Long | 2026-06-30 | |
| Janus Henderson Balanced Fund | — | 362,309 | $67,853,230 | 0.24% | Long | 2026-06-30 | |
| iShares MSCI USA Momentum Factor ETF | MTUM | 352,480 | $66,100,574 | 0.26% | Long | 2026-07-31 | |
| Fidelity Advisor Biotechnology Fund | — | 352,200 | $66,048,066 | 3.00% | Long | 2026-07-31 | |
| Janus Henderson Contrarian Fund | — | 348,053 | $65,183,366 | 1.19% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 370,778 | $58,390,119 | 0.04% | Long | 2026-05-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 361,340 | $56,903,823 | 0.96% | Long | 2026-05-29 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 297,199 | $55,659,429 | 0.24% | Long | 2026-06-30 | |
| Select Health Care Portfolio | — | 350,000 | $55,118,000 | 0.95% | Long | 2026-05-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 258,226 | $48,360,565 | 0.05% | Long | 2026-06-30 | |
| Fidelity Large Cap Growth Index Fund | FSPGX | 251,879 | $47,234,869 | 0.11% | Long | 2026-07-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 299,436 | $47,155,181 | 0.04% | Long | 2026-05-31 | |
| Dimensional U.S. Core Equity 2 ETF | DFAC | 240,308 | $45,064,959 | 0.09% | Long | 2026-07-31 | |
| Fidelity Advisor Health Care Fund | — | 240,300 | $45,063,459 | 1.44% | Long | 2026-07-31 | |
| Columbia Cornerstone Growth Fund | — | 226,688 | $42,510,801 | 0.66% | Long | 2026-07-31 |
Showing 1–50 of 530 positions
Key facts
CIK
1628171
CUSIP
76155X100
13F (30d)
17 filings
14 filers
Visit website
Investor relations